We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
+17.8%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$236M
AUM Growth
–
Cap. Flow
+$206M
Cap. Flow %
87.29%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$151M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$27.6M
3
ORIC icon
Oric Pharmaceuticals
ORIC
+$17.3M
4
YMAB
Y-mAbs Therapeutics
YMAB
+$10M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 88.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$25.8B
$178M 75.56%
+3,565,887
New +$151M
GDX icon
2
VanEck Gold Miners ETF
GDX
$27.6B
$26.6M 11.26%
+738,500
New +$27.6M
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.41B
$20.4M 8.63%
+602,272
New +$17.3M
YMAB
4
DELISTED
Y-mAbs Therapeutics
YMAB
$10.7M 4.55%
+216,916
New +$10M

Similar funds

BRC
Bishop Rock Capital New York $24.3M AUM 20.73% 1-Year Est. Return
NAM
Nationwide Asset Management Columbus, Ohio $25.1M AUM 13.37% 1-Year Est. Return
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Memorial Sloan Kettering Cancer Center's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Memorial Sloan Kettering Cancer Center, which disclosed 4 positions worth $236M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Royalty Pharma: 3,565,887 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets.

  • Memorial Sloan Kettering Cancer Center's largest Q4 2020 buy was Royalty Pharma: 3,565,887 shares worth $178M.
  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $236M portfolio in Q4 2020.
  • Memorial Sloan Kettering Cancer Center disclosed 4 positions in Q4 2020, its first 13F filing on record.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q4 2020, filed 16 Feb 2021.